Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Snapshot

Acute on chronic liver failure in cirrhosis

Marta Tonon, Salvatore Piano

Clin Mol Hepatol. 2022;28(2):273-275. Published online February 14, 2022

DOI: https://doi.org/10.3350/cmh.2022.0036

View: 3817 Download: 167 Citation: 1

Letter to the Editor

Reply: Letter: cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis

Jihyun An, Ju Hyun Shim

Clin Mol Hepatol. 2022;28(2):267-268. Published online January 18, 2022

DOI: https://doi.org/10.3350/cmh.2022.0013

View: 2225 Download: 46

Letter: cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis

Yi-Chun Huang, Chih-Wei Chen, James Chun-Chung Wei

Clin Mol Hepatol. 2022;28(2):265-266. Published online January 4, 2022

DOI: https://doi.org/10.3350/cmh.2021.0412

View: 5717 Download: 37 Citation: 1

Original Article

Galectin-3 inhibits cardiac contractility via a tumor necrosis factor alpha-dependent mechanism in cirrhotic rats

Ki Tae Yoon, Hongqun Liu, Jing Zhang, Sojung Han, Samuel S. Lee

Clin Mol Hepatol. 2022;28(2):232-241. Published online January 5, 2022

DOI: https://doi.org/10.3350/cmh.2021.0141

View: 3468 Download: 96 Citations: 3

Association between serum tumor necrosis factor-α and sarcopenia in liver cirrhosis

Ji Won Han, Da In Kim, Hee Chul Nam, U Im Chang, Jin Mo Yang, Do Seon Song

Clin Mol Hepatol. 2022;28(2):219-231. Published online July 20, 2021

DOI: https://doi.org/10.3350/cmh.2021.0082

View: 17743 Download: 295 Citations: 10

Editorial

Leaky gut-derived tumor necrosis factor-α causes sarcopenia in patients with liver cirrhosis

Takumi Kawaguchi, Takuji Torimura

Clin Mol Hepatol. 2022;28(2):177-180. Published online August 26, 2021

DOI: https://doi.org/10.3350/cmh.2021.0246

View: 3564 Download: 142 Citations: 2

Review

The role of transjugular intrahepatic portosystemic shunt in patients with portal hypertension: Advantages and pitfalls

Hae Lim Lee, Sung Won Lee

Clin Mol Hepatol. 2022;28(2):121-134. Published online September 27, 2021

DOI: https://doi.org/10.3350/cmh.2021.0239

View: 4918 Download: 326 Citations: 5

Original Article

U-shaped relationship between urea level and hepatic decompensation in chronic liver diseases

Huapeng Lin, Grace Lai-Hung Wong, Xinrong Zhang, Terry Cheuk-Fung Yip, Ken Liu, Yee Kit Tse, Vicki Wing-Ki Hui, Jimmy Che-To Lai, Henry Lik-Yuen Chan, Vincent Wai-Sun Wong

Clin Mol Hepatol. 2022;28(1):77-90. Published online November 5, 2021

DOI: https://doi.org/10.3350/cmh.2021.0188

View: 4228 Download: 122 Citations: 8

Cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis

Jihyun An, Hyung-Don Kim, Seon-Ok Kim, Ha Il Kim, Gi-Won Song, Han Chu Lee, Ju Hyun Shim

Clin Mol Hepatol. 2022;28(1):67-76. Published online October 12, 2021

DOI: https://doi.org/10.3350/cmh.2021.0202

View: 3895 Download: 166 Citations: 2

Review

Current knowledge about biomarkers of acute kidney injury in liver cirrhosis

Han Ah Lee, Yeon Seok Seo

Clin Mol Hepatol. 2022;28(1):31-46. Published online August 2, 2021

DOI: https://doi.org/10.3350/cmh.2021.0148

View: 5229 Download: 279 Citations: 8

Treatment of direct oral anticoagulants in patients with liver cirrhosis and portal vein thrombosis

Ho Soo Chun, A Reum Choe, Minjong Lee, Yuri Cho, Hwi Young Kim, Kwon Yoo, Tae Hun Kim

Clin Mol Hepatol. 2021;27(4):535-552. Published online June 16, 2021

DOI: https://doi.org/10.3350/cmh.2021.0109

View: 8714 Download: 533 Citations: 5

Changes in the epidemiology and management of bacterial infections in cirrhosis

Salvatore Piano, Marta Tonon, Paolo Angeli

Clin Mol Hepatol. 2021;27(3):437-445. Published online January 28, 2021

DOI: https://doi.org/10.3350/cmh.2020.0329

View: 5938 Download: 362 Citations: 20

β-blockers in advanced cirrhosis: More friend than enemy

Ki Tae Yoon, Hongqun Liu, Samuel S. Lee

Clin Mol Hepatol. 2021;27(3):425-436. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0234

View: 5331 Download: 247 Citations: 16

Anti-fibrotic treatments for chronic liver diseases: The present and the future

Naoshi Odagiri, Tsutomu Matsubara, Misako Sato-Matsubara, Hideki Fujii, Masaru Enomoto, Norifumi Kawada

Clin Mol Hepatol. 2021;27(3):413-424. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0187

View: 12241 Download: 447 Citations: 16

Original Article

Association between new-onset liver cirrhosis and suicide risk in South Korea: A nationwide cohort study

Suk-Yong Jang, Woo Sun Rou, Seok Hyun Kim, Byung Seok Lee, Hyuk Soo Eun

Clin Mol Hepatol. 2021;27(2):283-294. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0227

View: 4358 Download: 172 Citations: 5

Editorial

A need for patient-centered care in managing patients with liver cirrhosis

Eileen L. Yoon

Clin Mol Hepatol. 2021;27(2):270-272. Published online January 27, 2021

DOI: https://doi.org/10.3350/cmh.2021.0001

View: 2813 Download: 97 Citations: 2

Original Article

The cut-off value of transient elastography to the value of hepatic venous pressure gradient in alcoholic cirrhosis

Se Ri Ryu, Jeong-Ju Yoo, Seong Hee Kang, Soung Won Jeong, Moon Young Kim, Young Kyu Cho, Young Chang, Sang Gyune Kim, Jae Young Jang, Young Seok Kim, Soon Koo Baik, Yong Jae Kim, Su Yeon Park, Baigal Baymbajav

Clin Mol Hepatol. 2021;27(1):197-206. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0171

View: 5404 Download: 163 Citations: 8

Alcohol associated liver cirrhotics have higher mortality after index hospitalization: Long-term data of 5,138 patients

Priyanka Jain, Saggere Muralikrishna Shasthry, Ashok Kumar Choudhury, Rakhi Maiwall, Guresh Kumar, Ankit Bharadwaj, Vinod Arora, Rajan Vijayaraghavan, Ankur Jindal, Manoj Kumar Sharma, Vikram Bhatia, Shiv Kumar Sarin

Clin Mol Hepatol. 2021;27(1):175-185. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0068

View: 4167 Download: 115 Citations: 8

Editorial

Marta Tonon, Salvatore Piano

Clin Mol Hepatol. 2021;27(1):94-96. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0305

View: 3444 Download: 127 Citations: 3

The cutoff of transient elastography for the evaluation of portal hypertension should be different according to the etiology?

Beom Kyung Kim

Clin Mol Hepatol. 2021;27(1):91-93. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0311

View: 3040 Download: 82 Citations: 5

Review

The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future

Yusuke Watanabe, Atsunori Tsuchiya, Shuji Terai

Clin Mol Hepatol. 2021;27(1):70-80. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0194

View: 9979 Download: 355 Citations: 44

Managing liver cirrhotic complications: Overview of esophageal and gastric varices

Cosmas Rinaldi Adithya Lesmana, Monica Raharjo, Rino A. Gani

Clin Mol Hepatol. 2020;26(4):444-460. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0022

View: 9834 Download: 612 Citations: 48

Role of cytoglobin, a novel radical scavenger, in stellate cell activation and hepatic fibrosis

Le Thi Thanh Thuy, Hoang Hai, Norifumi Kawada

Clin Mol Hepatol. 2020;26(3):280-293. Published online June 4, 2020

DOI: https://doi.org/10.3350/cmh.2020.0037

View: 6475 Download: 221 Citations: 9

Letter to the Editor

Multimodal sequential treatment for occluded TIPS: Case report and review of literature

Nicoletta De Matthaeis, Carmine Di Stasi, Fabrizio Pizzolante, Riccardo Manfredi, Gian Ludovico Rapaccini, Luca Miele

Clin Mol Hepatol. 2020;26(2):227-230. Published online November 18, 2019

DOI: https://doi.org/10.3350/cmh.2019.0056

View: 5032 Download: 151

Guideline

KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications

Clin Mol Hepatol. 2020;26(2):83-127. Published online January 10, 2020

DOI: https://doi.org/10.3350/cmh.2019.0010n

View: 18818 Download: 1,291 Citations: 53

Letter to the Editor

Clinical characteristics of portal hypertension complicated by gastroesophageal varices in patients with myeloproliferative neoplasms

Jaejun Lee, Pil Soo Sung, Ki-Seong Eom, Hyun Yang, Soon Kyu Lee, Aung Hlaing Bwa, Angelo Lozada, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon

Clin Mol Hepatol. 2020;26(1):78-82. Published online November 26, 2019

DOI: https://doi.org/10.3350/cmh.2019.0078

View: 5325 Download: 165 Citations: 2

Transjugular intrahepatic portosystemic shunt assisted with trans-splenic access

Zhang Cheng, Feng Wang, Jianfei Liu

Clin Mol Hepatol. 2019;25(4):417-419. Published online June 19, 2019

DOI: https://doi.org/10.3350/cmh.2019.0030

View: 3799 Download: 116

Original Article

Incidence and risk factors of dysphagia after variceal band ligation

Saraswathi Arasu, Hammad Liaquat, Jaspreet Suri, Adam C. Ehrlich, Frank K. Friedenberg

Clin Mol Hepatol. 2019;25(4):374-380. Published online July 18, 2019

DOI: https://doi.org/10.3350/cmh.2019.0019

View: 5433 Download: 171 Citation: 1

Review

Sarcopenia: Ammonia metabolism and hepatic encephalopathy

Ankur Jindal, Rakesh Kumar Jagdish

Clin Mol Hepatol. 2019;25(3):270-279. Published online April 22, 2019

DOI: https://doi.org/10.3350/cmh.2019.0015

View: 14361 Download: 862 Citations: 51

Original Article

Portal pressure gradient and serum albumin: A simple combined parameter associated with the appearance of ascites in decompensated cirrhosis treated with transjugular intrahepatic portosystemic shunt

Dongmei Zhao, Guobing Zhang, Mingquan Wang, Chaoxue Zhang, Jiabin Li

Clin Mol Hepatol. 2019;25(2):210-217. Published online March 22, 2019

DOI: https://doi.org/10.3350/cmh.2018.0083

View: 5205 Download: 119 Citations: 5

Viewed By 4998	A decade of liver organoids: Advances in disease modeling
Viewed By 4746	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3910	Hepatitis B core-related antigen: A novel and promising surrogate biomarker to guide anti-hepatitis B virus therapy
Viewed By 3028	MAFLD: How is it different from NAFLD?
Viewed By 2468	Management of refractory ascites

Cited By 117	KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Cited By 54	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 52	From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
Cited By 46	Obesity and the risk of primary liver cancer: A systematic review and meta-analysis
Cited By 46	Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis

Cirrhosis and portal hypertension